The groundbreaking success of Viagra undeniably reshaped the medication landscape, but placing funds in companies heavily reliant on generic versions presents a uncertain picture. While early profits were impressive, the cessation of patents and the emergence of discounted alternatives have eroded market share. Thus, a thorough evaluation of presen